| Financial Year |
March 31 2023 |
| Monetary Funds |
2,264,916,026.94 |
| Held-for-trading Financial Assets |
287,306.50 |
| Notes Receivable |
39,441,463.86 |
| Accounts Receivable |
764,540,633.38 |
| Advances to Suppliers |
5,903,479.73 |
| Other Receivables |
7,317,581.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
39,769,813.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
462,163,401.23 |
| Total Current Assets |
3,662,911,204.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
89,283,303.81 |
| Investment Properties |
-- |
| Fixed Assetes |
16,595,854,839.49 |
| Under-construction Projects |
6,566,438,611.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,426,255,183.36 |
| R&D expenses |
11,705,722.74 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
228,131,844.80 |
| Deferred Income Tax Assets |
57,284,323.03 |
| Other Non-Current Assets |
355,192,260.45 |
| Sub-Total of Non-Current Assets |
26,387,638,012.18 |
| Total Assets |
30,050,549,216.80 |
| Short-Term Loans |
1,714,551,082.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,033,661,051.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
207,743,397.96 |
| Taxes Payable |
90,950,686.47 |
| Interest Payable |
-- |
| Dividend Payable |
1,482,817.12 |
| Other payables |
551,104,185.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,112,726,163.83 |
| Other Current Liabilities |
15,653,483.76 |
| Sub-Total of Current Liabilities |
5,956,094,818.76 |
| Long-term Loans |
5,370,983,119.90 |
| Bonds Payable |
1,685,473,667.96 |
| Long-Term Accounts Payable |
1,448,265,197.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,799,102,252.14 |
| Total Liabilities |
14,755,197,070.90 |
| Paid-In Capital(Or Share Stock) |
1,772,002,429.00 |
| Capital Surplus |
4,508,480,417.16 |
| Surplus Reserve |
474,365,378.75 |
| LESS:Treasury Stock |
25,873,675.94 |
| Undistributed Profits |
6,231,698,258.42 |
| Minority Stockholder's Interest |
2,152,699,139.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,142,653,006.87 |
| Owner's Equity（Stockholder's Equity） |
15,295,352,145.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,050,549,216.80 |
